Literature DB >> 7782289

The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family.

S S Apte1, B R Olsen, G Murphy.   

Abstract

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play a critical role in extracellular matrix homeostasis. We have previously cloned human and mouse TIMP-3 cDNAs and mapped their chromosomal loci (Apte, S. S., Mattei, M-G., and Olsen, B. R. (1994) Genomics 19, 86-90; Apte, S. S., Hayashi, K., Seldin, M. F., Mattei, M-G., Hayashi, M., and Olsen, B. R. (1994) Dev. Dynam. 200, 177-197); the identification of TIMP3 mutations in Sorsby's fundus dystrophy has underscored the functional importance of TIMP-3. We now report that TIMP-3 is encoded by five exons spanning over 30 kilobase pairs of mouse genomic DNA. In the attribution of protein domains to specific exons, as well as exon structures, the Timp-3 and Timp-1 genes are similar, confirming the common evolutionary origin of the TIMPs and defining a distinct gene family. We have expressed human and mouse TIMP-3 in mouse NSO myeloma cells. In each case, an N-glycosylated 27-kDa protein was generated, that, like TIMP-1 and TIMP-2, inhibited collagenase-1, stromelysin-1, and gelatinases A and B. TIMP-3 and TIMP-1 inhibition were quantitatively similar, implying that all TIMPs are equally efficient in MMP inhibition. Instead, differential regulation of the TIMP genes or divergent C-terminal protein sequences may underlie distinct biological functions for each TIMP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782289     DOI: 10.1074/jbc.270.24.14313

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.

Authors:  C Vaillant; M Didier-Bazès; A Hutter; M F Belin; N Thomasset
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism.

Authors:  M Clarke; K W Mitchell; J Goodship; S McDonnell; M D Barker; I D Griffiths; N McKie
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

Review 3.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

4.  Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1).

Authors:  H Nagase; K Suzuki; T E Cawston; K Brew
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 5.  Metalloproteinases, inflammation, and rheumatoid arthritis.

Authors:  F F Mohammed; D S Smookler; R Khokha
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

6.  Day/night rhythms in gene expression of the normal murine heart.

Authors:  Tami Martino; Sara Arab; Marty Straume; Denise D Belsham; Nazneen Tata; Fang Cai; Peter Liu; Maria Trivieri; Martin Ralph; Michael J Sole
Journal:  J Mol Med (Berl)       Date:  2004-02-24       Impact factor: 4.599

7.  Increased neovascularization in mice lacking tissue inhibitor of metalloproteinases-3.

Authors:  Quteba Ebrahem; Jian Hua Qi; Masahiko Sugimoto; Mariya Ali; Jonathan E Sears; Alecia Cutler; Rama Khokha; Amit Vasanji; Bela Anand-Apte
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-03       Impact factor: 4.799

8.  Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.

Authors:  M T Salmela; T T MacDonald; D Black; B Irvine; T Zhuma; U Saarialho-Kere; S L F Pender
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Authors:  C Fernandez-Catalan; W Bode; R Huber; D Turk; J J Calvete; A Lichte; H Tschesche; K Maskos
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

10.  Detection of novel biomarkers for ovarian cancer with an optical nanotechnology detection system enabling label-free diagnostics.

Authors:  Simon Kaja; Jill D Hilgenberg; Julie L Collins; Anna A Shah; Debra Wawro; Shelby Zimmerman; Robert Magnusson; Peter Koulen
Journal:  J Biomed Opt       Date:  2012-08       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.